Sana Biotechnology Inc. (NASDAQ:SANA) is one of the best emerging technology stocks to invest in. On December 8, Sana Biotechnology announced the publication of groundbreaking preclinical data in the ...

Cathie Wood has seldom shied away from letting everyone know where she believes the next wave of market-changing businesses ...

CRISPR became big in 2025, bringing advances for serious Indian health risks, which will continue in the coming year ...

The EPA is the authority charged with regulating biosafety and genome editing. Its tasks include granting permits, conducting risk assessments, and overseeing compliance. On the other hand, the Bio ...

Earlier in the week, ARK purchased 10,353 shares of CRISPR on Wednesday, valued at $584,530, and 43,333 shares on Tuesday, totaling $2,509,414. This consistent buying pattern suggests a strong ...

Detailed price information for Crispr Therapeutics Ag (CRSP-Q) from The Globe and Mail including charting and trades.

A dire wolf de-extinction debate, CRISPR-GPT for gene editing, and more topped the list of our most popular stories in ...

Here is the full list of the biotech and pharma Startup Battlefield 200 selectees, along with a note on what made us select ...

Cathie Wood’s ARK Invest ETFs (exchange-traded funds) made notable portfolio adjustments ahead of Christmas, on December 23, as revealed ...

Wondering if CRISPR Therapeutics is still a high risk biotech story or a quietly mispriced opportunity? This breakdown will help you decide whether the current share price makes sense for a long term ...

One important metric to look for in a stock is an 80 or higher Relative Strength Rating. CRISPR Therapeutics CRSP now clears that threshold, with a jump from 79 to 82 Tuesday. Please watch the video ...

It was the best of times, it was the worst of times for research in 2025. | It was the best of times and it was the worst of times for research in 2025. Medical breakthroughs and stunning discoveries ...